ACTL6A and central nervous system cancer: BAF53A, a member of the ATP-dependent switching (SWI)/sucrose fermentation (SNF) complex, has been implicated as an oncogenic driver, including CRC, hepatocellular carcinoma, glioma, and squamous cell carcinoma [5–9].